Accelerated Approval of New Frontline TKI Use in CML Raises Questions Kerry Dooley Young December 02, 2024 asciminib (Scemblix, Novartis AG)

https://www.medscape.com/viewarticle/accelerated-approval-new-frontline-tki-use-cml-raises-2024a1000lx4